This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (363) Stroke (207) Clinical Informatics (1190) Pharmacology and Pharmaceutics (91)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/70953, first published .
Clinical Efficacy and Safety of the Herbal Prescription, HH333, in Preventing Recurrent Stroke in Patients With Ischemic Stroke Induced by Small-Vessel Disease: Protocol for Multicenter, Double-Blind, Randomized, Prospective, Pilot Clinical Trial

Clinical Efficacy and Safety of the Herbal Prescription, HH333, in Preventing Recurrent Stroke in Patients With Ischemic Stroke Induced by Small-Vessel Disease: Protocol for Multicenter, Double-Blind, Randomized, Prospective, Pilot Clinical Trial

Clinical Efficacy and Safety of the Herbal Prescription, HH333, in Preventing Recurrent Stroke in Patients With Ischemic Stroke Induced by Small-Vessel Disease: Protocol for Multicenter, Double-Blind, Randomized, Prospective, Pilot Clinical Trial

Authors of this article:

Han-Gyul Lee1 Author Orcid Image ;   Seungwon Kwon1 Author Orcid Image ;   Woo-Sang Jung1 Author Orcid Image ;   Sang-Kwan Moon1 Author Orcid Image ;   Cheol-Hyun Kim2 Author Orcid Image ;   Dong-Jun Choi3 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.